Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
18,456 total articles
Two of American Airlines’ largest unions have shifted from contract-focused grievances to direct challenges to corporate leadership, asking the board to intervene amid persistent profit and reliability shortfalls compared with Delta and United. The pilots’ union has requested a meeting with the full board while the flight attendants’ union has issu…
BofA Securities downgraded Sanofi from "buy" to "neutral" and lowered its price objective to €92 from €102, citing a constrained catalyst outlook for 2026-27 and uncertainty following a management transition. The news weighed on the stock, which tumbled more than 6% on Thursday. BofA highlighted a reduced valuation multiple and specific upcoming tr…
Fincantieri updated its 2025 financial outlook and presented a new five-year plan for 2026-2030 at an investor presentation, increasing its 2025 EBITDA margin guidance and setting multi-year revenue and margin targets including projections for 2035. The disclosure was followed by a stock rise of 5.2%.
India's equity benchmarks closed lower on Thursday with the Nifty 50 down 0.57% and the BSE Sensex off 0.66%. Losses concentrated in Technology, Real Estate and Oil & Gas drove the retreat, even as Bajaj Finance, Shriram Finance and Eicher Motors posted gains. Market breadth favoured decliners and the India VIX rose modestly; key commodities and cu…
Novocure saw a significant premarket share rise after the U.S. Food and Drug Administration approved Optune Pax for use with gemcitabine and nab-paclitaxel in locally advanced pancreatic cancer. The device, which administers Tumor Treating Fields, produced modest survival benefits in Phase 3 testing and delayed pain progression, with the approval a…
Orkla closed 2024 with stronger-than-expected fourth-quarter organic growth across its Consolidated Portfolio Companies, driven by an outperforming Snacks division and robust Food Ingredients results. The company reported higher revenue, an improved adjusted EBIT margin, and adjusted earnings per share that exceeded analyst forecasts. Management id…
Flow Traders reported fourth-quarter EBITDA of €49.2 million, beating consensus by 9% as European operations delivered higher-than-expected revenue capture. Net trading income was €123.8 million, while the company signaled higher fixed operating expenses for 2026 than analysts had forecasted, with the midpoint implying double-digit growth in costs …
KBC Groep reported adjusted pre-tax profit for the fourth quarter of 2025 that modestly outpaced analyst estimates and provided forward guidance for 2026 and 2028 that sits above current consensus on several metrics. The quarter delivered stronger than expected net interest income and revenues, small additional operating costs and limited impairmen…
Carl Zeiss Meditec reported first-quarter results that missed consensus on sales and adjusted EBIT. Organic sales declined, key operating segments underperformed versus expectations, and the company has formally withdrawn its fiscal 2026 guidance while it reviews its outlook and strategy ahead of its six-month results in April.
Datwyler reported second-half 2025 sales of CHF538 million, a touch below expectations, while delivering stronger-than-expected profitability with a 12.6% EBIT margin. Full-year 2025 group sales reached CHF1.101 billion with an adjusted EBIT margin of 12.4%, up from 12.0% in 2024. The company proposed a CHF3.20 per share dividend and outlined a qua…
Unibail-Rodamco-Westfield reported full-year 2025 results highlighting the lowest EPRA vacancy rate since 2017 and positive revaluations across its portfolio. Adjusted recurring earnings per share for FY25 were €9.58, marginally below consensus, weighed by €1.6 billion of disposals completed in 2025. Tenant sales, footfall and net tangible assets p…
Kioxia reported stronger-than-expected third-quarter results and issued a fourth-quarter outlook that far exceeded consensus, prompting fresh gains across memory stocks. The company said its full NAND flash production capacity for 2026 is already sold out, while SSD, storage and smart device sales each showed year-over-year growth. Micron executive…
Sanofi has appointed Belén Garijo, 65, as its new chief executive after electing not to renew Paul Hudson's mandate. The move comes as the group contends with U.S. vaccine challenges and a lingering turnaround since 2019. Garijo brings prior Sanofi experience and recent leadership of Merck KGaA, where her record includes acquisitions, divestitures …
Cancom reported 0.9% year-on-year revenue growth in Q4 2025, marking a sequential acceleration after earlier declines in the year. EBITDA reached €38.6 million, an 8.0% margin versus 5.5% a year earlier, and cash flow strengthened in the quarter after a weaker first nine months of 2025. The company refrained from issuing 2026 guidance with prelimin…
AmBev delivered fourth-quarter results that broadly matched expectations on adjusted EBITDA but showed declines in volumes across most operating regions. Adjusted EBITDA came in at R$8.85 billion, 3% above analyst forecasts yet down 7.5% year-over-year. Total volumes fell 3.8% from a year earlier and missed analyst projections by 2.5%, with Brazil …
Samsung Electronics has started commercial shipments of its HBM4 high-bandwidth memory, becoming the first company to mass produce and ship this generation of memory. The company aims to reclaim market leadership after recent setbacks, is expanding capacity and expects substantial revenue growth from its HBM business by 2026. Competitors are also p…
Tietoevry reported fourth-quarter revenue a touch below consensus while outperforming on adjusted EBITA and margin after accelerated cost optimization. The company raised multi-year savings targets, outlined guidance for 2026 with continued growth headwinds, proposed a smaller dividend and launched a share buyback tied to a divestment.
Indonesian equities ended the session lower, with the IDX Composite Index closing down 0.65% in Jakarta. Losses were led by the Infrastructure, Financials and Agriculture sectors. A handful of small-cap winners posted double-digit gains, while several stocks dropped sharply, including one that hit an all-time low. Commodity and FX moves were modest…
European equities advanced on Thursday as investors parsed an extensive round of corporate earnings and digested U.K. growth figures. Major indexes in Germany, France and the U.K. gained, led by a mix of stronger-than-expected corporate updates and uneven results from a range of sectors. Mercedes Benz reported a sharp drop in profit and warned of m…
NN Group NV reported robust full-year 2025 results, with operating capital generation and solvency ratio ahead of market forecasts. The insurer proposed a higher-than-expected dividend, announced a €350 million buyback and flagged portfolio adjustments in response to rising disability claims related to long COVID.
Verisure PLC reported a standout fourth quarter driven by a record number of new installations, delivering annual recurring revenue growth that exceeded the company’s guidance. The security services provider widened margins in the quarter and closed 2025 with higher customer counts, modestly stronger operating profit than forecast, and guidance for…
Nextensa said it will propose a €1.00 dividend at its annual general meeting after reporting a return to profitability in fiscal 2025. The company logged a sharp fall in rental income driven by asset disposals but offset this with portfolio sales, lower net debt and higher earnings, while preparing to advance key development projects in 2026.
SwedenCare delivered fourth-quarter top-line growth while reporting a marked erosion in profitability. Net sales rose to SEK 682.3 million, marking 3% year-over-year growth and 11% organic expansion. However, operational profitability weakened materially as operational EBITDA and EBIT fell sharply due to a series of temporary cost and execution iss…
Camurus AB reported fourth-quarter results that missed analyst expectations on both revenue and profit, citing a SEK93 million one-time inventory repurchase tied to a UK distribution change and currency impacts. Sales of key products Buvidal and Brixadi came in below consensus, Oczyesa’s initial German launch produced limited uptake, and the compan…
Vimian Group reported fourth-quarter results that marginally beat consensus, with revenue of €109 million and adjusted EBITA of €26.1 million. The animal health company recorded 6% organic growth across its segments; Specialty Pharma and MedTech delivered margin improvements while Veterinary Services and Diagnostics saw margin compression tied to c…
